Tag Archives: Marrone Bio

Canaccord Genuity Reaffirms Their Buy Rating on Marrone Bio (MBII)

Canaccord Genuity analyst Robert Burleson maintained a Buy rating on Marrone Bio (MBII – Research Report) on February 24 and set a price target of $3.50. The company’s shares closed last Thursday at $2.25. Burleson has an average return of

Marrone Bio (MBII) Received its Third Buy in a Row

After Canaccord Genuity and H.C. Wainwright gave Marrone Bio (NASDAQ: MBII) a Buy rating last month, the company received another Buy, this time from Aegis Capital. Analyst Aegis Capital Corp. maintained a Buy rating on Marrone Bio yesterday and set

H.C. Wainwright Maintains a Buy Rating on Marrone Bio (MBII)

In a report released today, Amit Dayal from H.C. Wainwright maintained a Buy rating on Marrone Bio (MBII – Research Report), with a price target of $2.50. The company’s shares closed last Monday at $1.34. According to TipRanks.com, Dayal is

Marrone Bio (MBII) Receives a Buy from National Securities Corp

In a report released today, Ben Klieve from National Securities Corp maintained a Buy rating on Marrone Bio (MBII – Research Report), with a price target of $1.75. The company’s shares closed last Monday at $0.80, close to its 52-week

H.C. Wainwright Sticks to Their Buy Rating for Marrone Bio (MBII)

In a report released today, Amit Dayal from H.C. Wainwright maintained a Buy rating on Marrone Bio (MBII – Research Report), with a price target of $2.50. The company’s shares closed last Monday at $0.80, close to its 52-week low

National Securities Corp Remains a Buy on Marrone Bio (MBII)

National Securities Corp analyst Ben Klieve maintained a Buy rating on Marrone Bio (MBII – Research Report) today and set a price target of $2.50. The company’s shares closed last Monday at $1.02, close to its 52-week low of $1.00.